Back

Atrial posterior wall fibrosis >25% signals atrial fibrillation recurrence

12 April 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmia recurrences post atrial fibrillation ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Yuji Zhang

General Hospital of Northern Theater Command, Shenyang (China)

7 More presentations in this session

Presentation thumbnail
Identification of clinical risk factors for arrhythmia recurrence in atrail fibrillation patients undergoing catheter ablation: a systematic review and meta-analysis
Ms K. Chan (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Strategic factors to reduce recurrence after trido catheter ablation for atrial fibrillation
Doctor Y. Choi (Seoul, KR)
Abstract Slides
Presentation thumbnail
Incidence and predictors of atrial fibrillation recurrence after percutaneous ablation in the elderly population: insights from a single-center registry
Doctor H. Hussein (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
Defining the limits of pulmonary vein isolation: electroanatomic substrate predicts recurrence in first-time paroxysmal atrial fibrillation ablation
Doctor T. Baykaner (Stanford, US)
Abstract Slides Video
Presentation thumbnail
Real-world evaluation of atrial fibrillation burden and recurrence after ablation using ambulatory cardiac monitoring
Doctor M. Turakhia (Stanford, US)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmia recurrences post atrial fibrillation ablation

The Event

Event poster

EHRA 2026

12 April 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Lesion characteristics after atrial fibrillation ablation using pulsed field ablation
thumbnail
Congress Presentation
First-pass isolation as an independent predictor of atrial fibrillation recurrence after cryoballoon ablation in patients with persistent atrial fibrillation
thumbnail
Congress Presentation
Ppulsed field ablation and ultra-high-density mapping for PVI: use of machine learning and data augmentation to guide procedure and identify recurrent tachycardia mechanisms at one-year follow-up

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources